Table 1 Literature review of documented cases of human infection with L. sainthelensi since the pathogen was first described 1980
From: Severe bilateral pleuropneumonia caused by Legionella sainthelensi: a case report
References | Year | Number of case(s) | Country of diagnosis | Age | Sex | Comorbidity | Type of sample | Technique of identification | Antibiotic therapy | Death |
|---|---|---|---|---|---|---|---|---|---|---|
[6] | 1989 | 1 | Georgia, USA | Male | Pleural fluid | Culture on specific agar (BCYE1) | ||||
[6] | 1989 | 1 | Virginia, USA | Male | Sputum | Culture on specific agar (BCYE1) | ||||
[6] | 1989 | 1 | California, USA | 50 | Male | Diabetes, alcohol, tobacco, renal failure, chronic lung disease | Bronchoalveolar lavage (BAL) fluid | Culture on specific agar (BCYE1) | Erythromycin | Yes |
[8] | 1994 | 9 | Ontario, Canada | 69–102 | Serum | Serologic testing for L. sainthelensi-specific antibody2 | ||||
[7] | 2002–2014 | 1 | Texas, USA | 28 | Male | Acute leukemia, hematopoietic stem cell transplant, graft-versus-host disease | BAL fluid | Direct fluorescent antibody assay for Legionella species | Ceftriaxone, azithromycin, gatifloxacin | No |
[9] | 2001 | 1 | Christchurch, New Zealand | Culture on specific agar (BCYE) |